Skip to main content
. Author manuscript; available in PMC: 2018 Feb 15.
Published in final edited form as: Brain Res. 2016 Dec 30;1657:297–303. doi: 10.1016/j.brainres.2016.12.026

Figure 3. VPAC1 activation releases Ca2+ from IP3-sensitive Ca2+ stores in cardiac vagal neurons of nucleus ambiguus.

Figure 3

A, Characteristic increases in [Ca2+]i produced by VPAC1 agonist (100 nM) in Ca2+-free saline, in the absence and presence of lysosomal disruptor bafilomycin A1 (Baf), ryanodine receptor blocker ryanodine (Ry), IP3R inhibitors xestospongin C (XeC) and 2-aminoethoxydiphenyl borate (2-APB). B, Comparison of the effects on [Ca2+]i induced by treatments indicated in A, in cultured cardiac vagal neurons; *P < 0.05 as compared with VPAC1 agonist alone.